Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy - A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg.

Autor: Kött J; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. Electronic address: j.koett@uke.de., Zell T; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Zimmermann N; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Rünger A; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Smit DJ; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Abeck F; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Geidel G; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Hansen-Abeck I; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Heidrich I; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Weichenthal M; Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany., Ugurel S; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Germany., Leiter U; Division of Dermatooncology, Department of Dermatology, University Medical Center, Tuebingen, Germany., Berking C; Department of Dermatology, Uniklinikum Erlangen, Deutsches Zentrum Immuntherapie (DZI), Comprehensive Cancer Center Erlangen - EMN, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany., Gutzmer R; Department of Dermatology, Johannes Wesling Medical Center, Ruhr University Bochum, Minden, Germany., Schadendorf D; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Germany., Zimmer L; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Germany., Livingstone E; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Germany., Wasielewski IV; Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany., Mohr P; Elbe Clinic Buxtehude, Buxtehude, Germany., Meier F; Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Skin Cancer Center at the University Cancer Centre Dresden and National Center for Tumor Diseases, Dresden, Germany., Haferkamp S; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany., Drexler K; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany., Herbst R; Helios Skin Cancer Center, Helios Klinikum Erfurt, Germany., Kellner I; Helios Skin Cancer Center, Helios Klinikum Erfurt, Germany., Utikal J; Heidelberg University, Medical Faculty Mannheim, Department of Dermatology and National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital Heidelberg, Heidelberg, Germany., Wohlfeil SA; Heidelberg University, Medical Faculty Mannheim, Department of Dermatology and National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital Heidelberg, Heidelberg, Germany., Pföhler C; Saarland University Medical School, Department of Dermatology, Homburg, Saar, Germany., Adam L; Saarland University Medical School, Department of Dermatology, Homburg, Saar, Germany., Terheyden P; Department of Dermatology, University of Lübeck, Lübeck, Germany., Ulrich J; Department of Dermatology and Skin Cancer Center, Harzklinikum Dorothea Christiane Erxleben, Quedlinburg, Germany., Meiss F; Department of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Möbes M; Department of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Welzel J; Department of Dermatology, University Hospital Augsburg, Germany., Schilling B; Department of Dermatology, University Hospital Würzburg, Würzburg, Germany., Ziller F; Department of Dermatology, DRK Krankenhaus Rabenstein, Chemnitz, Germany., Kaatz M; Department of Dermatology, DRK Krankenhaus Rabenstein, Chemnitz, Germany., Kreuter A; Department of Dermatology, Venereology, and Allergology, Helios St. Elisabeth Hospital Oberhausen, University Witten-Herdecke, Oberhausen, Germany; Department of Dermatology, Venereology, and Allergology, Helios St. Johannes Hospital Duisburg, Germany., Sindrilaru A; Department of Dermatology, University Hospital Ulm, Germany., Dippel E; Department of Dermatology, Ludwigshafen Medical Center, Ludwigshafen, Germany., Sachse M; Skin Cancer Center, Department of Dermatology, Allergology and Phlebology, Bremerhaven Reinkenheide Medical Center, Bremerhaven, Germany., Weishaupt C; Department for Dermatology and Venereology, University Clinic Münster, Münster, Germany., Hüning S; Department of Dermatology, Hospital of Dortmund, Dortmund, Germany., Heinzerling L; Department of Dermatology, Uniklinikum Erlangen, Deutsches Zentrum Immuntherapie (DZI), Comprehensive Cancer Center Erlangen - EMN, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany; Department of Dermatology, LMU University Hospital, LMU Munich, Munich, Germany., Loquai C; Department of Dermatology and Allergology, Klinik Bremen-Mitte, Bremen, Germany., Schley G; Department of Dermatology, Helios Kliniken Schwerin, Schwerin, Germany., Gambichler T; Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Bochum, Germany., Löffler H; Department of Dermatology, SLK-Kliniken Heilbronn, Heilbronn, Germany., Grabbe S; Department of Dermatology, University of Mainz Medical Center, Mainz, Germany., Schultz E; Department of Dermatology, Nürnberg General Hospital, Paracelsus Medical Center, Nürnberg, Germany., Devereux N; Skin Cancer Center Hamburg, Department of Dermatosurgery Tabea/HOPA, Hamburg, Germany., Hassel JC; Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany., Simon JC; Department of Dermatology, Venerology and Allergology, Skin Cancer Center, Leipzig University Medical Center, Leipzig, Germany., Raap U; University Clinics of Dermatology and Allergy, University of Oldenburg, Oldenburg, Germany., Assaf C; Department of Dermatology, Helios Klinikum Krefeld, Krefeld, Germany., Klemke CD; Department of Dermatology and Skin Cancer Center, Hospital Karlsruhe, Karlsruhe, Germany., Sunderkötter C; Department of Dermatology and Venereology, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Halle, Germany., Hofmann SC; Center for Dermatology, Allergy and Dermatosurgery, HELIOS University Hospital Wuppertal, University Witten/Herdecke, Germany., Wenk S; Department of Dermatology, Klinikum Darmstadt, Darmstadt, Germany., Tronnier M; Department of Dermatology, Helios Klinikum Hildesheim, Hildesheim, Germany., Thies S; Department of Dermatology, Asklepios Klinikum Uckermark, Schwedt/Oder, Germany., Heppt MV; Department of Dermatology, Uniklinikum Erlangen, Deutsches Zentrum Immuntherapie (DZI), Comprehensive Cancer Center Erlangen - EMN, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany., Eggermont A; Comprehensive Cancer Center Munich of the Technical University Munich and the Ludwig Maximilians University, Munich, Germany., Schulze HJ; Department of Dermatology, Fachklinik Hornheide, Münster, Germany., Zouboulis CC; Departments of Dermatology, Venereology, Allergology and Immunology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany., Tüting T; Department of Dermatology, University Hospital Magdeburg, Magdeburg, Germany., Bauer AT; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Schneider SW; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. Electronic address: st.schneider@uke.de., Gebhardt C; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. Electronic address: ch.gebhardt@uke.de.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Nov 30; Vol. 214, pp. 115159. Date of Electronic Publication: 2024 Nov 30.

Effectiveness, safety and utilization of cobimetinib and vemurafenib in patients with BRAF V600 mutant melanoma with and without cerebral metastasis under real-world conditions in Germany: the non-interventional study coveNIS.

Autor: Kähler KC; UKSH Schleswig-Holstein, Campus Kiel, Klinik für Dermatologie Venerologie und Allergologie, Kiel., Debus D; Klinikum Nürnberg, Hautklinik, Universitätsklinik für Dermatologie der Paracelsus Medizinischen Privatuniversität, Nürnberg., Schley G; HELIOS Klinikum Schwerin und universitärer Campus der MSH-Medical School Hamburg, Hautklinik, Schwerin., Göppner D; Universitätsklinikum Gießen, Klinik für Dermatologie Venerologie und Allergologie, Gießen., Hassel JC; Universitätsklinikum Heidelberg, Hautklinik und Nationales Centrum für Tumorerkrankungen, Heidelberg., Meier F; Klinik und Poliklinik für Dermatologie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Hauttumorzentrum am Nationalen Centrum für Tumorerkrankungen und Universitäts KrebsCentrum Dresden, Dresden., Terheyden P; UKSH Schleswig-Holstein, Campus Lübeck, Klinik für Dermatologie Allergologie und Venerologie, Lübeck., Stadler R; Universitätsklinik für Dermatologie, Johannes Wesling Klinikum, Minden, Klinikum der Ruhr-Universität Bochum (UK-RUB)., Tüting T; Universitätshautklinik Magdeburg, Klinik für Dermatologie und Venerologie, Magdeburg., Kaatz M; SRH Wald-Klinikum gGmbH, Klinik für Hautkrankheiten und Allergologie, Gera., Hoff NP; Universitätsklinikum Düsseldorf, Klinik für Dermatologie, Düsseldorf., Masoudi E; Roche Pharma AG, Grenzach-Wyhlen., Zdanowicz-Specht A; Roche Pharma AG, Grenzach-Wyhlen., Nguyen MT; Roche Pharma AG, Grenzach-Wyhlen., Mohr P; Elbe Klinikum Buxtehude, Klinik für Dermatologie, Buxtehude, Germany.

Publikováno v: Melanoma research [Melanoma Res] 2024 Feb 01; Vol. 34 (1), pp. 44-53. Date of Electronic Publication: 2023 Nov 13.

1099P COMBI-EU: Adverse event management of adjuvant dabrafenib plus trametinib (D+T) in patients with BRAF V600-mutant melanoma

Autor: Mohr, P., Debus, D., von Wasielewski, I., Tüting, T., Gebhardt, C., Heppt, M.V., Hassel, J.C., Ziller, F., Weichenthal, M., Aoun, M., Schley, G., Ulrich, J., Utikal, J., Meier, F., Terheyden, P., Gutzmer, R., Schadendorf, D.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S728-S729

Strikingly conserved gene expression changes of polyamine regulating enzymes among various forms of acute and chronic kidney injury.

Autor: Sieckmann T; Institute of Translational Physiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Schley G; Department of Nephrology and Hypertension, Friedrich-Alexander University Erlangen-Nürnberg (FAU), University Hospital Erlangen, Erlangen, Germany., Ögel N; Institute of Translational Physiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Kelterborn S; Institute of Translational Physiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Boivin FJ; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; Molecular and Translational Kidney Research, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Fähling M; Institute of Translational Physiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Ashraf MI; Department of Surgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Reichel M; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Vigolo E; Molecular and Translational Kidney Research, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Hartner A; Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander University Erlangen-Nürnberg (FAU), University Hospital Erlangen, Erlangen, Germany., Lichtenberger FB; Institute of Translational Physiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Breiderhoff T; Department of Pediatrics, Division of Gastroenterology, Nephrology and Metabolic Diseases, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Knauf F; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Rosenberger C; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Aigner F; Department of Surgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; Department of Surgery, St. John of God Hospital Graz, Graz, Austria., Schmidt-Ott K; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; Molecular and Translational Kidney Research, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany; Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany., Scholz H; Institute of Translational Physiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Kirschner KM; Institute of Translational Physiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. Electronic address: karin.kirschner@charite.de.

Publikováno v: Kidney international [Kidney Int] 2023 Jul; Vol. 104 (1), pp. 90-107. Date of Electronic Publication: 2023 Apr 28.

Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG.

Autor: Franklin C; Department of Dermatology and Venereology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany cindy.franklin@uk-koeln.de.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Cologne, Germany., Mohr P; Department of Dermatology, Elbe-Kliniken Buxtehude, Buxtehude, Germany., Bluhm L; Department of Dermatology, Elbe-Kliniken Buxtehude, Buxtehude, Germany., Meier F; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden and, Skin Cancer Center at the University Cancer Center Dresden and National Center for Tumor Diseases (NCT), Dresden, Germany., Garzarolli M; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden and, Skin Cancer Center at the University Cancer Center Dresden and National Center for Tumor Diseases (NCT), Dresden, Germany., Weichenthal M; Department of Dermatology, Skin Cancer Center, Schleswig-Holstein University Hospital, Campus Kiel, Kiel, Germany., Kähler K; Department of Dermatology, Skin Cancer Center, Schleswig-Holstein University Hospital, Campus Kiel, Kiel, Germany., Grimmelmann I; Skin Cancer Center Hannover, Department of Dermatology, Hannover Medical School, Hanover, Germany., Gutzmer R; Department of Dermatology, Muehlenkreiskliniken Minden and Ruhr University Bochum, Minden, Germany., Utikal J; Skin Cancer Unit, German Cancer Research Center (DKFZ) and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany., Terheyden P; Department of Dermatology, University of Lübeck and Schleswig-Holstein University Hospital, Campus Lübeck, Lübeck, Germany., Herbst R; Department of Dermatology, HELIOS Klinikum Erfurt, Erfurt, Germany., Haferkamp S; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany., Pfoehler C; Department of Dermatology, Saarland University Medical School, Homburg, Homburg/Saar, Germany., Forschner A; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany., Leiter U; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany., Ziller F; Department of Dermatology, DRK Hospital Chemnitz-Rabenstein, Chemnitz, Germany., Meiss F; Department of Dermatology and Venereology, Medical Center, University of Freiburg, Freiburg im Breisgau, Germany., Ulrich J; Department of Dermatology and Skin Cancer Center, Harzklinikum Dorothea Christiane Erxleben, Quedlinburg, Germany., Kreuter A; Department of Dermatology, Venereology and Allergology, Helios St. Elisabeth Klinik Oberhausen, University Witten-Herdecke, Oberhausen, Germany., Gebhardt C; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Welzel J; Department of Dermatology and Allergology, University Hospital Augsburg, Augsburg, Germany., Schilling B; Department of Dermatology and Venereology, University Hospital Würzburg, Würzburg, Germany., Kaatz M; Department of Dermatology, SRH Wald-Klinikum Gera, Gera, Germany., Scharfetter-Kochanek K; Department of Dermatology and Venereology, University Hospital Ulm, Ulm, Germany., Dippel E; Department of Dermatology, Ludwigshafen Medical Center, Ludwigshafen, Germany., Nashan D; Department of Dermatology, Hospital of Dortmund, Dortmund, Germany., Sachse M; Skin Cancer Center, Department of Dermatology, Klinikum Bremerhaven Reinkenheide, Bremerhaven, Germany., Weishaupt C; Department of Dermatology, University Hospital of Muenster, Muenster, Germany., Löffler H; Department of Dermatology, SLK-Kliniken Heilbronn, Heilbronn, Germany., Gambichler T; Department of Dermatology, Ruhr-University Bochum, Bochum, Germany., Loquai C; Department of Dermatology, Klinikum Bremen-Ost, Gesundheit Nord gGmbH, Bremen, Germany.; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Heinzerling L; Department of Dermatology and Allergology, Ludwig-Maximilian University, Munich, Germany., Grabbe S; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Debus D; Department of Dermatology, Nuremberg General Hospital, Paracelsus Medical University, Nuremberg, Germany., Schley G; Department of Dermatology and Venereology, Helios Klinikum Schwerin, Schwerin, Germany., Hassel JC; National Center for Tumor Diseases (NCT), Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany., Weyandt G; Department of Dermatology and Allergology, Hospital Bayreuth, Bayreuth, Germany., Trommer M; Department of Radiation Oncology and Cyberknife Center, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Lodde G; Department of Dermatology, Venereology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK) Partner Site Essen, Essen, Germany., Placke JM; Department of Dermatology, Venereology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK) Partner Site Essen, Essen, Germany., Zimmer L; Department of Dermatology, Venereology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK) Partner Site Essen, Essen, Germany., Livingstone E; Department of Dermatology, Venereology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK) Partner Site Essen, Essen, Germany., Becker JC; Department of Dermatology, Venereology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK) Partner Site Essen, Essen, Germany.; Translational Skin Cancer Research, German Cancer Consortium (DKTK), Deutsches Krebsforschungszentrum, Heidelberg, Germany., Horn S; Department of Dermatology, Venereology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK) Partner Site Essen, Essen, Germany.; Rudolf-Schönheimer-Institute of Biochemistry, Medical Faculty of the University Leipzig, Leipzig, Germany., Schadendorf D; Department of Dermatology, Venereology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK) Partner Site Essen, Essen, Germany., Ugurel S; Department of Dermatology, Venereology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK) Partner Site Essen, Essen, Germany.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Apr; Vol. 11 (4).